Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Ototoxicity × Cisplatin × Clear all

Phase

Phase NA 1 Phase EARLY_PHASE1 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 126 Lung Neoplasms 50 Nasopharyngeal Carcinoma 49 Uterine Cervical Neoplasms 43 Squamous Cell Carcinoma of Head and Neck 41 Head and Neck Neoplasms 39 Stomach Neoplasms 29 Parkinson Disease 4, Autosomal Dominant Lewy Body 29 Esophageal Neoplasms 26 Urinary Bladder Neoplasms 20 Small Cell Lung Carcinoma 19 Esophageal Squamous Cell Carcinoma 18 Ovarian Neoplasms 13 Carcinoma 12 Neoplasm Metastasis 11 Recurrence 10 Cholangiocarcinoma 10 Biliary Tract Neoplasms 10 Neuroblastoma 9 Gallbladder Neoplasms 9 Carcinoma, Transitional Cell 8 Carcinoma, Ovarian Epithelial 8 Adenocarcinoma Of Esophagus 8 Testicular Neoplasms 7 Nasopharyngeal Neoplasms 7 Central Nervous System Neoplasms 7 Teratoma 6 Neoplasms 6 Mesothelioma, Malignant 6 Carcinoma, Squamous Cell 6

Interventions

sodium thiosulfate 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Cisplatin 1 Chemotherapy, Adjuvant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00652132 2018-05-29

SIOPEL6

University of Birmingham

Phase 3 Completed

116 enrolled 1 FDA

Gastrointestinal

Ototoxicity, Liver Neoplasms, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡